Therapeutic potential of Panax ginseng and its constituents, ginsenosides and gintonin, in neurological and neurodegenerative disorders: a patent review

References

• Moon Y, Sung J, An R, et al. Gait variability in people with neurological disorders: a systematic review and meta-analysis. Hum Mov Sci. 2016;47:197–208.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Shojaei S, Yeganeh B, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24–49.
   PubMed Web of Science ®Google Scholar
• Mufson EJ, Ikonomovic MD, Counts SE, et al. Molecular and cellular pathophysiology of preclinical Alzheimer’s disease. Behav Brain Res. 2016 Sep;15(311):54–69.
   Google Scholar
• Hardy J. The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal. J Neurochem. 2009 Aug;110(4):1129–1134.
   PubMed Web of Science ®Google Scholar
• Dal Prà I, Chiarini A, Gui L, et al. Do astrocytes collaborate with neurons in spreading the “infectious” abeta and Tau drivers of Alzheimer’s disease? Neuroscientist. 2015 Feb;21(1):9–29.
   PubMed Web of Science ®Google Scholar
• Heusinkveld HJ, Wahle T, Campbell A, et al. Neurodegenerative and neurological disorders by small inhaled particles. Neurotoxicology. 2016;56:94–106.
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med. 2015 Mar;47(3):e147.
   PubMed Web of Science ®Google Scholar
• Buendia I, Michalska P, Navarro E, et al. Nrf2-ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther. 2016;157:84–104.
   PubMed Web of Science ®Google Scholar
• Abdel-Salam OME Use of herbal products/alternative medicines in neurodegenerative diseases (Alzheimer’s disease and Parkinson’s disease). In: Singh S, Joshi N, editors. Pathology, prevention and therapeutics of neurodegenerative disease. Springer; 2019:279–301.
   Google Scholar
• Zhu JD, Wang JJ, Zhang XH, et al. Panax ginseng extract attenuates neuronal injury and cognitive deficits in rats with vascular dementia induced by chronic cerebral hypoperfusion. Neural Regen Res. 2018 Apr;13(4):664–672.
   PubMed Web of Science ®Google Scholar
• Kim DH. Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J Ginseng Res. 2012 Jan;36(1):1–15.
   PubMed Web of Science ®Google Scholar
• Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol. 2009. 7. Jul(3):293–302.
   Google Scholar
• Murthy HN, Georgiev MI, Kim YS, et al. Ginsenosides: prospective for sustainable biotechnological production. Appl Microbiol Biotechnol. 2014;98(14):6243–6254.
   PubMed Web of Science ®Google Scholar
• Shin BK, Kwon SW, Park JH. Chemical diversity of ginseng saponins from Panax ginseng. J Ginseng Res. 2015 Oct;39(4):287–298.
   PubMed Web of Science ®Google Scholar
• Jeong KJ, Kim GW, Chung SH. AMP-activated protein kinase: an emerging target for ginseng. J Ginseng Res. 2014 Apr;38(2):83–88.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim P, Shin CY. A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J Ginseng Res. 2013 Mar;37(1):8–29.
   PubMed Web of Science ®Google Scholar
• Lee CH, Kim J-H. A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases. J Ginseng Res. 2014 Jul;38(3):161–166.
   PubMed Web of Science ®Google Scholar
• Lee JH, Jeong SM, Lee BH, et al. Prevention of ginsenoside-induced desensitization of Ca2+-activated Cl− current by microinjection of inositol hexakisphosphate in Xenopus laevis oocytes: involvement of GRK2 and beta-arrestin I. J Biol Chem. 2004 Mar 12;279(11):9912–9921.
   PubMed Web of Science ®Google Scholar
• Park SY, Park JH, Kim HS, et al. Systems-level mechanisms of action of Panax ginseng: a network pharmacological approach. J Ginseng Res. 2018 Jan;42(1):98–106.
   PubMed Web of Science ®Google Scholar
• Choi S, Rho SH, Jung SY, et al. A novel activation of Ca2+‐activated Cl− channel in Xenopus oocytes by Ginseng saponins: evidence for the involvement of phospholipase C and intracellular Ca2+ mobilization. Br J Pharmacol. 2001 Feb;132(3):641–648.
   PubMed Web of Science ®Google Scholar
• Kim KH, Lee D, Lee HL, et al. Beneficial effects of Panax ginseng for the treatment and prevention of neurodegenerative diseases: past findings and future directions. J Ginseng Res. 2018 Jul;42(3):239–247.
   PubMed Web of Science ®Google Scholar
• Jia L, Zhao Y. Current evaluation of the millennium phytomedicine-ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations. Curr Med Chem. 2009;16(19):2475–2484.
   PubMed Web of Science ®Google Scholar
• Sun Y. Structure and biological activities of the polysaccharides from the leaves, roots and fruits of Panax ginseng CA Meyer: an overview. Carbohydr Polym. 2011;85(3):490–499.
   Web of Science ®Google Scholar
• Nah SY. Gintonin: a novel ginseng-derived ligand that targets G protein-coupled lysophosphatidic acid receptors. Curr Drug Targets. 2012 Dec;13(13):1659–1664.
   PubMed Web of Science ®Google Scholar
• Pyo MK, Choi SH, Shin TJ, et al. A simple method for the preparation of crude gintonin from ginseng root, stem, and leaf. J Ginseng Res. 2011 Jun;35(2):209–218.
   PubMed Web of Science ®Google Scholar
• Pyo MK, Choi SH, Shin TJ, et al. Novel glycolipoproteins from ginseng. J Ginseng Res. 2011 Jun;35(2):209–218.
   PubMed Web of Science ®Google Scholar
• Choi SH, Jung SW, Lee BH, et al. Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions. Front Pharmacol. 2015 Oct;27(6):245.
   Google Scholar
• Luo H, Hu J, Wang Y, et al. In vivo and in vitro neuroprotective effects of Panax ginseng glycoproteins. Int J Biol Macromol. 2018 Jul;1(113):607–615.
   Google Scholar
• Juanfang L, Ming S, Gang Z, inventors; Fourth Military Medical Univ., assignee. Application of panaxoside Rd in preparing medicament for preventing and curing Alzheimer’s disease. China patent CN101766642 (A). 2010 Jul 7.
   Google Scholar
• Lee SE, Kim GS, Lee DY, et al., inventors; Republic of Korea (Management: Rural Dev Administration), assignee. Ginseng extract having cognition enhancing activity and manufacturing method thereof. Korea patent KR20170054157 (A). 2017 May 17.
   Google Scholar
• Fu L, Wang K, Fu Q, et al., inventors; FU LI, assignee. Use of ginsenoside-rg3 in preparing medicine for preventing or/and treating dementia and medicine. US patent US2016271154 (A1). 2016 Aug 22.
   Google Scholar
• Lavalle JB, inventor; Natural Formulations, Lavalle James B., assignee. Compositions, therapeutic and prophylactic methods for treatment of neurodegenerative diseases and brain injuries. WO patent WO2016122832 (A1). 2016 Aug 4.
   Google Scholar
• Fu L, Lu Q, inventors; Fu Li assignee. Aqueous solution of 20(R)-ginsenoside RG3 pharmaceutical composition and process thereof USA patent US9333215 (B2). 2016 May 10.
   Google Scholar
• Zhang Y, Gu C, Zhu H, et al., inventors; Kunming Institute Of Botany, Chinese Academy of Sciences, assignee. C3, C6, C17-trisubstituted dammarane type triterpenoid saponin derivative, pharmaceutical composition thereof and applications of derivative in pharmacy. China patent CN105061541 (B). 2017 Apr 5.
   Google Scholar
• Luo M, Hu Y, Yang J, et al., inventors; Chengdu Biopurify Phytochemicals Ltd., assignee. Ginseng stem and leaf effective part and preparation method and application thereof. China patent CN105477035 (A). 2016 Apr 13.
   Google Scholar
• Na SY, Kim JH, inventors, Konkuk University Industry-Academia Collaboration Foundation, assignee, Composition comprising gintonin for acetylcholine synthesis improvement. Korea patent KR20150041297 (A). 2015 Apr 16.
   Google Scholar
• Nah SY, Han JS, CHung CH, inventors; Univ Konkuk Ind Coop Corp., assignee. Cognitive enhancement by gintonin-mediated synaptic transmission increase via lysophosphatidic acid receptor activation in hippocampus. Korea patent KR20160062364 (A). 2016 Jun 2.
   Google Scholar
• Na SY, Kim HJ, inventors; Konkuk University Industry-Academia Collaboration Foundation, assignee. Composition comprising gintonin for neural progenitor cells proliferation or neurogenesis improvement. Korea patent KR20150041298 (A). 2015 May 16.
   Google Scholar
• Kim H, Boo YM, inventors; University-Industry Cooperation Group of Kyung Hee University, assignee. Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases. USA patent US2010055213 (A1). 2010 Mar 4.
   Google Scholar
• Solomon D, Gomez HG, inventors; Allegiance Equity Corporation, assignee. Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng. USA patent US2011212191 (A1). 2011 Dec 1.
   Google Scholar
• Beutler RD, Schmidt K, inventors; Merz Pharma GmbH & Co. KGaA, assignee. Compartment-specific plant extract combination of ginkgo biloba extract and ginseng extract having a tandem effect. USA patent US2011034563 (A1). 2011 Feb 10
   Google Scholar
• Kim BD, Park JH, Ryu J, inventors; Ginseng Science Inc., assignee. Composition comprising an extract of combined herbs consisting of ginseng and Vitis genus plant for preventing and treating Neuro-degenerative disease and enhancing memory power patent US2014234445 (A1). 2014 Aug 21.
   Google Scholar
• Hao L, Jiangang L, Longtao L, et al., inventors; Xiyuan Hospital Of China Academy Of Chinese Medical Sciences, assignee. Traditional Chinese medicine for preventing and treating Alzheimer disease and preparation method thereof. Chinese patent CN102078460 (A). 2011 Jun 1.
   Google Scholar
• Libin L, Yanni X, Seqing Y, et al., inventors; Guangdong Yihe Pharmaceutical Co Ltd, assignee. Chinese medicament for preventing and treating agrypnia, memory loss and alzheimers disease and method Chinese patent CN101850058 (A). 2010 Nov 6.
   Google Scholar
• Laxiang P, inventor; Laixiang Pang, assignee. Traditional Chinese medicine composition for treating hypophrenia and senile dementia and preparation method and detection method thereof Chinese patent CN102085282 (A). 2011 Jun 8.
   Google Scholar
• Shibo D, Tongtong C, inventors; Shandong Inst Of Pharmaceutica, assignee. Chinese medicinal composition for Alzheimer’s symptoms and preparation method thereof. Chinese patent CN101502601 (A). 2009 Aug 12.
   Google Scholar
• Ju SS, inventor; Kangnung Wonju National University Industry-University Collaboration Foundation, assignee. Novel composition for enhancing cognitive function of Alzheimer’s patients. Korean patent KR101640002 (B1). 2016 May 15.
   Google Scholar
• Li Q, Wang L, inventors; Li Qingjie, assignee. Drug composition conducive to improvement of memory and adjunctive treatment of senile dementia. Chinese patent CN103041060 (A). 2013 Apr 17.
   Google Scholar
• Kim SY, Choi SJ, Kim CR, et al., inventors; Kim Soon Young, assignee. A composition comprising the extract of Plantago asiatica and Panax ginseng for preventing improving and treating degenerative brain disease. Korean patent KR101748301 (B1). 2017 Jun 20.
   Google Scholar
• Fang Y, Xue Z, Fang R, et al., inventors; The First Affiliated Hospital Of Guangzhou University Of Chinese Medicine, assignee. Pharmaceutical composition for preventing and treating alzheimer disease and preparation method of pharmaceutical composition. Chinese patent CN103735761 (B). 2016 Sep 7.
   Google Scholar
• Zhang Z, Zhang T, inventors; Guizhou Maqika Invest Co Ltd., assignee. Traditional Chinese medicine composition for treating Alzheimer’s diseases and preparation method of traditional Chinese medicine composition. Chinese patent CN103071048 (B). 2014 Sep 17.
   Google Scholar
• Kim BD, Park JH, Ryu JH, inventors; Ginseng Science, assignee. A composition comprising the extract of combined herb of Panax ginseng and Vitis genus plant treating and preventing neuro-degenerative disease and enhancing memory power Korean patent KR101367885 (B1). 2014 Mar 11.
   Google Scholar
• Yonghe Z, Xinzhi C, Mingxing W, et al., inventors; Pharmaceutical composition for treating Alzheimer disease symptom and its preparation method. Chinese patent CN102188471 (A). 2011 Sep 21.
   Google Scholar
• Wang Y, inventor; Yu Tejin, assignee. A method of treating cognitive dysfunction pharmaceutical compositions and the use of Alzheimer’s disease in the preparation of. Chinese patent CN103566087B. 2013 Oct 17.
   Google Scholar
• Ss JOO, inventor; Gangneung Wonju Nat University Industry Academy Cooperation Group, assignee. Novel composition for treating alzheimer’s disease and improving cognitive function of alzheimer’s patients. US patent US2016022751 (A1). 2016 Jan 28.
   Google Scholar
• Wang D, Li X, Sun J, et al., inventors; Wang Desheng, assignee. Medicine composition for treating senile dementia and preparation method thereof Chinese patent CN103505550 (B). 2015 Oct 14.
   Google Scholar
• Yi X, inventor; Yi Xu, assignee. Pharmaceutical composition for treating AD (Alzheimer’s disease) and preparation method of pharmaceutical composition. China patent CN105878649A. 2016 Aguust 24.
   Google Scholar
• Ju SS, inventor; Kangnung Wonju National University Industry-University Collaboration Foundation, assignee. Amyloid Novel composition for treating and alleviating disease by the accumulation of -amyloid Korean patent KR101732886 (B1). 2017 May 24.
   Google Scholar
• Du Z, Deng J, Hao E, et al., inventors; Guangxi University Of Chinese Medicine, assignee. Traditional Chinese medicine composition for treating senile dementia and preparation method thereof. Chinese patent CN104055852 (B). 2016 Apr 13.
   Google Scholar
• Meng X, Gao R, inventors; Meng Xiaobin, assignee. Traditional Chinese medicine preparation for treating alzheimer disease and preparation method. Chinese patent CN103550537 (B). 2014 Aug 6.
   Google Scholar
• Liang S, Zeng Y, Wu Z, et al., inventors; Shenzhen Inst Of Gerontology, Wu Zhengzhi, Liang Shaoyu, Zeng Yongchang, assignee. Traditional Chinese medicine composition for prophylaxis and treatment of Alzheimer disease and preparation method thereof Chinese patent CN105920476 (A). 2016 Sep 7.
   Google Scholar
• Yin J, Meng Q, Yang Y, et al., inventors; Univ Jilin, assignee. Traditional Chinese medicinal composition preparation for preventing and treating senile dementia and preparation method thereof. Chinese patent CN103705845 (A). 2014 Apr 9.
   Google Scholar
• Kim YO, Lee SW, Kim HD, inventors; Republic of Korea(Management: Rural Development Administration), assignee. Composition having brain function and congnition enhancing activity comprising ginseng mixed herbal extracts, ginsenoside Rg2 and ginsenoside F2. Korean patent KR101509056 (B1). 2015 Apr 8.
   Google Scholar
• Feng Y, Jiandong W, Jing Y, et al., inventors; Shanghai Yushengtang Tech Co Ltd, assignee. Medicinal composition for treating Alzheimer disease. Chinese patent CN105853589 (A). 2016 Aug 17.
   Google Scholar
• Wang Y, inventor; Yu Tejin, assignee. Pharmaceutical composition for treating cognitive disorder and application thereof in preparation of medicine for treating Alzheimer disease. Chinese patent CN103566087 (A). 2014 Feb 12.
   Google Scholar
• Cui J, inventor; Hanshan Shaoguan Yinghuang Oil Co Ltd., assignee. Walnut oil for preventing Alzheimer’s disease. Chinese patent CN104855543 (A). 2015 Aug 26.
   Google Scholar
• Li G, Qu G, Xie F, et al., inventors; Jilin Changbai Lvye Ginseng Industry Co Ltd, assignee. Ginseng composition and application thereof in aspect of adjunctively improving memory. Chinese patent CN103239606 (A). 2013 Aug 14.
   Google Scholar
• Zheng M, assignee. Preparation for treating senile dementia and preparation method. China patent CN105148022 (A). 2015 Dec 16.
   Google Scholar
• Feng F, Zhao J, Qu W, et al., inventors; Univ China Pharma., assignee. Chinese medicinal composition for preventing and treating senile dementia. Chinese patent CN105687582 (A). 2016 Jun 22.
   Google Scholar
• Zhang Z, Zhang T, inventors; Guizhou Shenqi Pharmaceutical Res Inst, assignee. Traditional Chinese medicine composition. Chinese patent CN105521306 (A). 2016 Mar 27.
   Google Scholar
• Liang S, Zeng Y, Wu Z inventors; Shenzhen Gerontology Res Institute, Wu Zhengzhi, Zeng Yongchang, assignee. Traditional Chinese medicine composition for reversing Abeta amyloid protein injured nerve cells as well as preparation method and application thereof. Chinese patent CN107007784 (A). 2017 Aug 4.
   Google Scholar
• Tian J, Shi J, inventors; Tian Jinzhou, Shi Jing, assignee. Medicinal composition for treating Alzheimer’s disease and preparation method and application of medicinal composition. Chinese patent CN106692551 (A). 2017 May 24.
   Google Scholar
• Kim SC, Han JH, Seokseae C, inventors; Intelligent Biosystem Design and Synthesis Research Foundation, assignee. F1 The composition containing ginsenoside F1 for removing amyloid plaques. Korean patent KR101777920 (B1). 2017 Sep 14.
   Google Scholar
• Pakr KS, Hwang JY, Shim JS, inventors; Univ-Industry Coop Group of Kyung Hee Univ., assignee. Rb1 Rg1 composition comprising ginsenoside-rb1 and a ginsenoside-rg1 for protecting neuronal cells. Korean patent KR20170058035 (A). 2017 May 26.
   Google Scholar
• Qu L, Chen H, Zhang Y, et al., inventors; Scient Res Training Center for Chinese Astronauts, assignee. Medicine composition and application thereof for treating memory disorder. Chinese patent CN105943545 (A). 2016 Sep 21
   Google Scholar
• Kim SY, Choi SJ, Kim CW, et al., inventors; Kim Soon-young, assignee. A composition comprising the extract of Plantago asiatica and Panax ginseng for preventing improving and treating degenerative brain disease. Korean patent KR101748301 (B1). 2017 Jun 20.
   Google Scholar
• Hur JY, Kim SS, Kim KT, et al., inventors; Korea Food Res Inst., assignee. Rg18 pharmaceutical composition for improving preventing or treating degenerative disease comprising ginsenoside Rg18. Korean patent KR101771679 (B1). 2017 Aug 29.
   Google Scholar
• H Ferreira-Vieira T, M Guimaraes I, R Silva F, et al. Alzheimer’s disease: targeting the cholinergic system. Curr Neuropharmacol. 2016;14(1):101–115.
   PubMed Web of Science ®Google Scholar
• Naghdi M, Tiraihi T, Mesbah-Namin SA, et al. Induction of bone marrow stromal cells into cholinergic-like cells by nerve growth factor. Iran Biomed J. 2009 Apr;13(2):117–123.
   PubMedGoogle Scholar
• Joo SS, inventor; Gangneung Wonju Nat University Industry Academy Cooperation Group, assignee. Novel composition for treating alzheimer’s disease and improving cognitive function of alzheimer’s patients. US patent US2016022751 (A1). 2016 Apr 28.
   Google Scholar
• Lian X, Zhang Y, Zhang Z, et al., inventors; Univ Zhejiang, assignee. Preparation of panaxadiol saponins component and pharmaceutical application for prevention and treatment of Parkinson disease. Chinese patent CN102727508 (B). 2014 Sep 24.
   Google Scholar
• Lu W, inventor; Beijing Ludekaiqi Business Co Ltd., assignee. Combined immunization medicine for treating Parkinson’s disease as well as preparation method and application of medicine. Chinese patent CN105878548 (A). 2016 Aug 24.
   Google Scholar
• Kim HC, Sin EJ, Ko SK, inventors; Knu-Industry Cooperation Foundation, Semyung University Division Of Industry-Academy Cooperation Group, assignee. Pharmaceutical composition for the prevention and treatment of parkinson’s disease and alzheimer’s disease containing ginseng fructus extract. Korean patent KR101581497 (B1). 2015 Dec 30.
   Google Scholar
• Bei W, Guo J, inventors; Univ Guangdong Pharm, assignee. Preparation and application of flavonol as brain-targeting synergist. WO patent WO2016107579 (A1). 2016 Jul.
   Google Scholar
• Guanfu Z, inventor; Guizhou Xinbang Pharmaceutical Co Ltd., assignee. Pharmaceutical composition for cardio cerebrovascular diseases. Chinese patent CN102309497 (A). 2012 Jan 11.
   Google Scholar
• Yu X, Yu X, Zhang Y, et al., inventors; Changchun University Of Chinese Medicine, assignee. Traditional Chinese medicine composition with function of assisting improvement of memory and preparation method thereof. Chinese patent CN104225417 (A). 2014 Dec 24.
   Google Scholar
• Lu Z, Cheng M, Tang Y, inventors; The Second Affiliated Hospital of Suzhou Univ, assignee. Application of panaxoside Rg1 in preparing medicine for restoring spinal cord injury and method for constructing mouse spinal cord injury model. Chinese patent CN106692169 (A). 2017 May 24.
   Google Scholar
• Lian X, Guo X, Zhang Z, et al., inventors; Univ Zhejiang, assignee. Application of panaxadiol saponins fraction in preparing medicine for preventing epilepsia. Chinese patent CN102743401 (B). 2014 Jul 2.
   Google Scholar
• Lian X, Qian H, Zhang Z, et al., inventors; Zhejiang University, assignee. Application of panaxadiol saponin component in preparing antischizophrenic drug. Chinese patent CN104224817 (B). 2017 Apr 26.
   Google Scholar
• Yutang C, inventor; Yutang Chen, assignee. Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like. Chinese patent CN102343038 (A). 2012 Feb 8.
   Google Scholar
• Wang J, Zhang W, Wang Y, et al., inventors; Univ Jiangsu, assignee. Application of ginseng pectin in resisting depressive behavior. Chinese patent CN105287671 (A). 2016 Feb 3.
   Google Scholar
• Ersalan M, Tekin M, inventors; Eraslan Mustafa Mustafa Tekin, assignee. Tribulus terrestris, avena sativa and panax ginseng extract combination. France patent WO2013028140 (A1). 2013 Feb 28.
   Google Scholar
• Wang J, Lu S, Yang Z, inventors; Shanghai Innovative Research Center Of Traditional Chinese Medicine, assignee. Application of protopanaxadiol derivative and protopanaxatriol derivative in preparation of drugs. Chinese patent CN103961358 (B). 2016 Jun 6.
   Google Scholar
• Han P, Guo R, Zhou Y, et al., inventors; Han Ping, assignee. Traditional Chinese medicine formula for treating Parkinsonism. chinese patent CN104800604 (A). 2015 Jul 29.
   Google Scholar
• Choi BT, Baek JU, Shin HK, inventors; Pusan Nat Univ Industry-Univ Coop Found, assignee. Composition for prevention or treatment of neurodegenerative diseases. Korean patent KR20170055701 (A). 2017 May 22
   Google Scholar
• Zhang L, inventor; Zhang Lidong, assignee. Medicine for treating Parkinson Chinese patent CN103393809 (A). 2013 Nov 20.
   Google Scholar
• Du Z, Deng J, Hao E, et al., inventors; Univ Guangxi Chinese Medicine, assignee. Traditional Chinese medicine composition for treating senile dementia and preparation method thereof. Chinese patent CN104055852 (A). 2014 Sep 24.
   Google Scholar
• Zhu Y, Tsim KWK, Dong TX, et al., inventors; Univ Hong Kong Science & Tech, assignee. Pharmaceutical composition and preparation method thereof. Chinese patent CN105535302 (A). 2016 May 4.
   Google Scholar
• Yang H, Li S, Wang Y, et al., inventors; Inst Chinese Materia Medica China Academy Of Cms, assignee. Composition of chinese herbal compound or extract and use thereof. Chinese patent CN103108645 (B). 2015 Jul 15.
   Google Scholar
• Luan L, Shi Q, Wu Y, et al., inventors; Univ Zhejiang, assignee. Composition containing tenuifoliside and ginsenoside. Chinese patent CN104840527 (A). 2015 Aug 19.
   Google Scholar
• Han Z, Jiping F, inventors; Zhenyun Han, assignee. Traditional Chinese medicine for treating vascular dementia and preparation method thereof. Chinese patent CN101926929 (A). 2010 Dec 29.
   Google Scholar
• Wei Z, Li Z, Shang J, et al., inventors; Kpc Pharmaceuticals Inc, assignee. Dengyin naotong pharmaceutical composition and preparation method thereof, preparation and application thereof. Chinese patent CN105287614 (A). 2016 Feb 3.
   Google Scholar
• Choi BT, Shin HK, Baek JU, inventors; Pusan Nat Univ Industry-Univ Coop Found, assignee. Composition for treating improving or preventing neurodegenerative diseases. Korean patent KR20160149853 (A). 2016 Dec 28.
   Google Scholar
• Yang R, Yan Z, Lu Y, inventors; Shanghai Jiaotong Univ School of Medicine, assignee. Traditional Chinese medicine compound extract product and application thereof. Chinese patent CN105816495 (A). 2016 May 3.
   Google Scholar
• Yang H, Li S, Wang Y, et al., inventors; Institute of Chinese Medicine, China Academy of Chinese Medical Sciences. Composition containing Chinese medicine active ingredients and application thereof. Chinese patent CN102861117 (A). 2013 Jan 9.
   Google Scholar
• Kim KT, Rhee YK, Kim SS, et al., inventors; Korea Food Res Inst, assignee. Composition improved antioxidant activity containing extract of ginseng seeds. Korean patent KR20140120759 (A). 2014 Oct 14.
   Google Scholar
• Wu MK, Weng CF, Sie HW, et al., inventors; Spiranthes Biotech Llc., assignee. Compositions containing a spiranthes sinensis extract and pharmaceutical applications thereof. Chinese patent CN107427546 (A). 2017 Dec 1.
   Google Scholar
• Tsuda M, Fukuchi M, Mori H, inventors; Nat Univ Corp Univ of Toyama, assignee. Agent and composition for inducing expression of brain-derived neurotrophic facto. WO patent WO2017104706 (A1). 2017 Jun 22.
   Google Scholar
• Jiao W, Lin W, Yun J, et al., inventors; Xinxinag Medical University, assignee. Effective component of CLMD (Chaihu-jia-Longgu-Muli-Decoction) for treating mental sickness and preparation method of effective component. Chinese patent CN104353004 (A). 2015 Feb 18.
   Google Scholar
• Li G, Qu G, Xie F, et al., inventors; Jilin Changbai Lvye Ginseng Industry Co Ltd., assignee. Ginseng composition and application thereof in aspect of adjunctively improving memory. Chinese patent CN103239606 (A). 2013 May 14.
   Google Scholar
• Hao L, Liu J, Longtao L, et al., inventors; Xiyuan Hospital Of China Academy of Chinese Medical Sciences, assignee. Traditional Chinese medicine for preventing and treating Alzheimer disease and preparation method thereof. Chinese patent CN102078460 (A). 2011 Jun 1.
   Google Scholar
• Cook-Deegan R, Niehaus A. After Myriad: genetic testing in the wake of recent supreme court decisions about gene patents. Curr Genet Med Rep. 2014;2(4):223–241.
   PubMedGoogle Scholar
• Hefferon K. Plant biotechnology patents: applications in agriculture and medicine. Recent Pat Biotechnol. 2010 Jun;4(2):136–152.
   PubMedGoogle Scholar
• Yun TK. Brief introduction of Panax ginseng C.A. Meyer. J Korean Med Sci. 2001 Dec;16 Suppl:S3–5.
   PubMed Web of Science ®Google Scholar
• Ahmed T, Raza SH, Maryam A, et al. Ginsenoside Rb1 as a neuroprotective agent: a review. Brain Res Bull. 2016;125:30–43.
   PubMed Web of Science ®Google Scholar
• Jakaria M, Kim J, Karthivashan G, et al. Emerging signals modulating potential of ginseng and its active compounds focusing on neurodegenerative diseases. J Ginseng Res. 2018:1–8. DOI: 10.1016/j.jgr.2018.01.001
   PubMedGoogle Scholar
• Oh J, Kim JS. Compound K derived from ginseng: neuroprotection and cognitive improvement. Food Funct. 2016 Nov 9;7(11):4506–4515.
   PubMed Web of Science ®Google Scholar
• Song L, Xu MB, Zhou XL, et al. A preclinical systematic review of Ginsenoside-Rg1 in experimental Parkinson’s disease. Oxid Med Cell Longev. 2017;2017:2163053.
   PubMedGoogle Scholar
• Cho IH. Efects of Panax ginseng in neurodegenerative diseases. J Ginseng Res. 2012 Oct;36(4):342–353.
   PubMed Web of Science ®Google Scholar
• Radad K, Gille G, Liu L, et al. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci. 2006 Mar;100(3):175–186.
   PubMed Web of Science ®Google Scholar
• Rameshrad M, Razavi BM, Hosseinzadeh H. Saffron and its derivatives, crocin, crocetin and safranal: a patent review. Expert Opin Ther Pat. 2018 Feb;28(2):147–165.
   PubMed Web of Science ®Google Scholar
• Bedrood Z, Rameshrad M, Hosseinzadeh H. Toxicological effects of Camellia sinensis (green tea): A review. Phytother Res. 2018 Jul;32(7):1163–1180.
   PubMed Web of Science ®Google Scholar
• Lüde S, Vecchio S, Sinno-Tellier S, et al. Adverse effects of plant food supplements and plants consumed as food: results from the poisons centres-based plant LIBRA study. Phytother Res. 2016 Jun;30(6):988–996.
   PubMed Web of Science ®Google Scholar
• Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological effects of Glycyrrhiza glabra (Licorice): a review. Phytother Res. 2017 Nov;31(11):1635–1650.
   PubMed Web of Science ®Google Scholar
• Choi HS, Kim S, Kim MJ, et al. Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial. J Ginseng Res. 2018 Jan;42(1):90–97.
   PubMed Web of Science ®Google Scholar
• Park SJ, Noh J, Jeong EJ, et al. Subchronic oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats with a 4-week recovery period. Regul Toxicol Pharmacol. 2018;92:83–93.
   PubMed Web of Science ®Google Scholar
• Gadkariem EA, Al-Ashban RM, Babikir LB, et al. Toxicity study of Korean ginseng herbal medicine. Res J Pharmacol. 2010;4(4):86–90.
   Google Scholar
• Rastogi V, Santiago-Moreno J, Dore S. Ginseng: a promising neuroprotective strategy in stroke. Front Cell Neurosci. 2015 Jan 20;8:457.
   PubMed Web of Science ®Google Scholar
• Ramanathan MR, Penzak SR. Pharmacokinetic drug interactions with Panax ginseng. Eur J Drug Metab Pharmacokinet. 2017 Aug;42(4):545–557.
   PubMed Web of Science ®Google Scholar
• Dong WW, Han XZ, Zhao J, et al. Metabolite profiling of ginsenosides in rat plasma, urine and feces by LC-MS/MS and its application to a pharmacokinetic study after oral administration of Panax ginseng extract. Biomed Chromatogr. 2018 Mar;32(3). doi:10.1002/bmc.4105.
   Web of Science ®Google Scholar